|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Non-alcoholic fatty liver disease(NAFLD),insulin resistance and lipid profile in antiepileptic drug treatment显示文摘 | Luef G Rauchenzauner M Waldmann M | 2009 | Epilepsy Res2009，86，1： | 1 |
| 2 | Polycystic ovaries,obesity and insulin resistance in women with epilepsy,A comparative study of carbamazepine and valproic acid in 105 women显示文摘 | Luef G Abramham I Haslinger M | 2002 | J Neurol2002，249，7： | 1 |
| 3 | Adiponectin receptor R1 is upregulated by valproic acid but not by topiramate in human hepatoma cell line, HepG2显示文摘 | RAUCHENZAUNER M LAIMER M LUEF G | 2008 | Seizure-European Journal of Epilepsy2008，17，8： | 1 |
| 4 | Valproic acid modulares islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients显示文摘 | Luef GJ Lechleitner M Bauer G | 2003 | Epilepsy Res2003，55，： | 1 |
| 5 | Epilepsy and hormones: A critical review 显示文摘 | Luef G Rauehenzauner M | 2009 | Epilepsy Behav2009，15，1： | 1 |
| 6 | Valproic acid modulates islet cell insulin secretion: a possible mechanism of weight gain in epilepsy patients显示文摘 | Luef GJ Lechleitner M Bauer G | 2003 | Epilepsy Res2003，55，： | 1 |
| 7 | Cardiovascular risk factors in epilepsy patients taking levetiracetam, carbamazepine or lamotrigine 显示文摘 | Svalheim S Luef G Rauchenzauner M | 2010 | Acta Neurol Scand2010，，190： | 1 |
| 8 | Epilepsy and hormones: a critical re- view显示文摘 | Luef G Rauchenzauner M | 2009 | Epilepsy Behav2009，15，1： | 1 |
| 9 | Polycystic ovaries, obe- sity and insulin resistance in women with epilepsy, A compara- tive study of carbamazepine and valproicacid in 105 women显示文摘 | Luef G Abramham I Haslnger M | 2002 | J Neurol2002，249，7： | 1 |
| 10 | Polycystic ovaries, obesity and insulin resistance in women with epilepsy,a comparative study of carbamazepine and valproic acid in 105 women显示文摘 | Luef G Abramham I Haslinger M | 2002 | J Neurol2002，249，7： | 1 |
| 11 | Increase in postprandial serum insulin levels in epileptic with valproic acid therapy显示文摘 | Luef G Abraham I Hoppichler F Trinka E Unterberger I Bauer G Lechleitner M | 2002 | Metabolism2002，51，10： | 1 |
| 12 | Valproic acid modulates islet cell insulin secretion: a possible mechanisms of weight gain in epilepsy patients 显示文摘 | Luef GL Lechleitner M Bauer G Trinka E Hengster P | 2003 | Epilepsy Res2003，55，12： | 1 |
| 13 | Polycystic ovaries,obesity and insulin resistance in women with epilepsy:A comparative study of carbamazepine and valproic acid in 105 women 显示文摘 | LUEF G ABRAHAM I HASLINGER M | 2002 | J Neurol2002，249，7： | 1 |
| 14 | Non-alcoholic fatty liver disease ( NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment 显示文摘 | Luef M Rauchenzauner M Waldmann W Sturm A Sandhofer K Seppi E | 2009 | Epilepsy Research2009，86，1： | 1 |
| 15 | Polycystic ovaries, obesity and insulin resistance in women with epilepsy: A comparative study of carhamazepine and valproic acid in 105 women 显示文摘 | Luef G Abraham I Haslinger M | 2002 | J Neurol2002，249，7： | 1 |
| 16 | Valproic acid modulates islet cell insulin secretion:a possible mechanism of weight gain in epilepsy patients显示文摘 | Luef GJ Lechleitner M Bauer G | 2003 | Epilepsy Res2003，55，12： | 1 |
| 17 | Polycystic ovaries,obesity and insulin resistance in women with epilepsy,A comparative study of carbamazepine and valproic acid in 105 women显示文摘 | LUEF G ABRAMHAM I HASLINGER M | 2002 | J Neurol2002，249，7： | 1 |
| 18 | Poly-cystic ovaries, obesity and insulin resistance in women with epilepsy: A comparative study of carhamazepine and valproic acid in 105 women 显示文摘 | LUEF G ABRAHAM I HASLINGER M | 2002 | J Neurol2002，249，7： | 1 |
| 19 | Valproic acid modulates islet cell insulinsecretion:a possible mechanism of weight gain in epilepsy patients显示文摘 | Luef GJ Lechleitner M Bauer G | 2003 | EpilepsyRes2003，55，12： | 1 |
| 20 | Non-alcoholic fatty liver disease(NAFLD), insulin resistance and lipid profile in antiepi- leptic drug treatment显示文摘 | Luef G Rauchenzauner M Waldmann M | 2009 | Epilepsy Res2009，86，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员